Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit

Conclusion Phase I clinical trials can be considered a reasonable option in selected patients with relapsed UGIC. The use of objective prognosticators may improve selection and risk/benefit profile of patients.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research